Primary intestinal lymphangiectasia

Current Treatment Options in Gastroenterology

Volumn 7, Issue 1, 2004, Pages 3-6

  Bliss Jr , Charles M ^a   Schroy III, Paul C ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIPLASMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORPROMAZINE; DIURETIC AGENT; INSULIN; MEDIUM CHAIN TRIACYLGLYCEROL; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; TRANEXAMIC ACID;

ABDOMINAL PAIN; BRADYCARDIA; CHYLOUS ASCITES; DIARRHEA; DRUG ABSORPTION; DRUG COST; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG POTENTIATION; FIBRINOLYSIS; FLU LIKE SYNDROME; HEART ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; HYPOALBUMINEMIA; HYPOGLYCEMIA; INTESTINE LYMPHANGIECTASIA; LOW FAT DIET; MALABSORPTION; NAUSEA; PALLIATIVE THERAPY; PERICARDIAL EFFUSION; PERIPHERAL EDEMA; PERITONEUM VEIN SHUNT; PLEURA EFFUSION; PRESCRIPTION; PROTEIN DIET; PROTEIN LOSING GASTROENTEROPATHY; REVIEW; SEIZURE; SMALL INTESTINE RESECTION; STEATORRHEA; THROMBOEMBOLISM; VOMITING;

EID: 3142697007     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-004-0019-z     Document Type: Review

References (14)

1. Salomons HA, Kramer P, Nikulasson R, Schroy PC: Endoscopic features of long-standing primary intestinal lymphangiectasia. Gastrointest Endosc 1995, 41:516-518.
2. Tift WL, Lloyd JK: Intestinal lymphangiectasia: long-term results with MCT diet. Arch Dis Child 1975, 50:269-276.
3. Vardy PA, Lebenthal E, Shwachman H: Intestinal lymphangiectasia: a reappraisal. Pediatrics 1975, 55:842-851.
4. MacLean JE, Cohen E, Weinstein M: Primary intestinal and thoracic lymphangiectasia: a response to antiplasmin therapy. Pediatrics 2002, 109:1177-1180.
5. Mine K, Matsubayashi S, Nakai Y, et al.: Intestinal lymphangiectasia markedly improved with antiplasmin therapy. Gastroenterology 1989, 96:1596-1599.
6. Bac DJ, Van Hagen PM, Postema PT, el al.: Octreotide for protein-losing enteropathy with intestinal lymphangiectasia. Lancet 1995, 345:1639.
7. Heikenen JB, Pohl JF, Werlin SL, et. al.: Octreotide in pediatric patients. J Pediatr Gastroenterol Nutr 2002, 35:600-609.
8. Jackson R, Pencharz PB: Intestinal lymphangiectasia and octreotide. J Pediatr Gastroenterol Nutr 2001, 33:408-409.
9. Muzaffar K, Block MA, Fox TA Jr: Primary intestinal lymphangiectasia: surgical implications. Am Surg 1972, 38:288-291.
10. Persic M, Browse NL, Prpic I: Intestinal lymphangiectasia and protein-losing enteropathy responding to small bowel resection. Arch Dis Child 1998, 78:194.
11. Uguralp S, Mutus M, Kutlu O, et al.: Primary intestinal lymphangiectasia: a rare disease in the differential diagnosis of acute abdomen. J Pediatr Gastroenterol Nutr 2001, 33:508-510.
12. White SM: Operative ascitic drainage in a patient with primary intestinal lymphangiectasia. Anaesthesia 2003, 58:396-397.
13. Heresbach D, Raoul JL, Bretagne JF, et al.: Intestinal lymphangiectasia: lack of efficacy of antiplasmin therapy? Gastroenterology 1991, 100:1152-1153.
14. Mine K: Intestinal lymphangiectasia: lack of efficacy of antiplasmin therapy? [comment]. Gastroenterology 1991, 101:1761.